Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Envista Holdings Corporation (NVST) stocks in Canada

Learn how to easily invest in Envista Holdings Corporation stocks.

Envista Holdings Corporation is a medical instruments & supplies business based in the US. Envista Holdings Corporation stocks (NVST.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $43.77 – a decrease of 4.26% over the previous week. Envista Holdings Corporation employs 12,400 staff and has a trailing 12-month revenue of around $2.8 billion.

How to buy shares in Envista Holdings Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NVST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Envista Holdings Corporation stock price (NYSE:NVST)

Use our graph to track the performance of NVST stocks over time.

Envista Holdings Corporation shares at a glance

Information last updated 2022-01-16.
Latest market close$43.81
52-week range$33.75 - $46.88
50-day moving average $42.68
200-day moving average $42.37
Wall St. target price$51.11
PE ratio 22.6899
Dividend yield N/A (0%)
Earnings per share (TTM) $2.04

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Envista Holdings Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Envista Holdings Corporation price performance over time

Historical closes compared with the close of $43.81 from 2022-01-19

1 week (2022-01-13) -4.26%
1 month (2021-12-20) 9.17%
3 months (2021-10-20) 12.56%
6 months (2021-07-20) 7.22%
1 year (2021-01-20) 19.41%
2 years (2020-01-17) 36.78%
3 years (2019-01-16) N/A
5 years (2017-01-16) N/A

Is Envista Holdings Corporation under- or over-valued?

Valuing Envista Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Envista Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Envista Holdings Corporation's P/E ratio

Envista Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Envista Holdings Corporation shares trade at around 23x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Envista Holdings Corporation's EBITDA

Envista Holdings Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $598.4 million.

The EBITDA is a measure of a Envista Holdings Corporation's overall financial performance and is widely used to measure a its profitability.

Envista Holdings Corporation financials

Revenue TTM $2.8 billion
Operating margin TTM 16.75%
Gross profit TTM $1.2 billion
Return on assets TTM 4.49%
Return on equity TTM 8.07%
Profit margin 12.85%
Book value $24.47
Market capitalisation $7.5 billion

TTM: trailing 12 months

Envista Holdings Corporation share dividends

We're not expecting Envista Holdings Corporation to pay a dividend over the next 12 months.

Envista Holdings Corporation share price volatility

Over the last 12 months, Envista Holdings Corporation's shares have ranged in value from as little as $33.75 up to $46.88. A popular way to gauge a stock's volatility is its "beta".

NVST.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Envista Holdings Corporation's is 1.7511. This would suggest that Envista Holdings Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Envista Holdings Corporation overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site